Type
1.
Lima Santana N, Rêgo JL, Oliveira JM, Almeida LF, Braz M, Machado LMM, et al. Polymorphisms in genes TLR1, 2 and 4 are associated with differential cytokine and chemokine serum production in patients with leprosy. Memorias do Instituto Oswaldo Cruz [Internet]. 2017;112(4):260-8. Available from: http://www.scielo.br/pdf/mioc/v112n4/0074-0276-mioc-0074-02760160366.pdf
Type
1.
Sousa JR, Sousa RPM, Aarão TLS, Dias LB, Oliveira Carneiro FR, Quaresma JAS. Response of iNOS and its relationship with IL-22 and STAT3 in macrophage activity in the polar forms of leprosy. Acta tropica. 2017;
Type
1.
Oliveira ALG, Chaves AT, Menezes CAS, Guimarães NS, Bueno LL, Fujiwara RT, et al. Vitamin D Receptor Expression and Hepcidin Levels in the Protection or Severity of Leprosy: a Systematic Review. Microbes and infection. 2017;
Type
1.
Dubey A, Biswas SK, Sinha E, Chakma JK, Kamal R, Arora M, et al. Association of Nitric Oxide Synthase2 gene polymorphisms with leprosy reactions in northern Indian population. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2017;
Type
1.
Nongrum B, Chacko S, Mathew PT, Paulson. Corneal astigmatism in leprosy and its importance for cataract surgery. Leprosy review [Internet]. 2017;88(1):154-8. Available from: https://leprosyreview.org/article/88/1/15-4158
Type
1.
Sasidharanpillai S, Govindan A, Riyaz N, Binitha M, Parambath SP, Khader A, et al. Histopathology of skin lesions of leprosy before and after fixed duration treatment. Leprosy review [Internet]. 2017;88(1):142-53. Available from: https://leprosyreview.org/article/88/1/14-2153
Type
1.
Polycarpou A, Walker SL Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK, Lockwood DN. A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum. Frontiers in immunology [Internet]. 2017;8:233. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346883/pdf/fimmu-08-00233.pdf
Type
1.
Regional Office for South-East Asia, World Health Organization, Al-Qubati Y, Beise K, Castalia R. Global leprosy strategy 2016-2020: Accelerating towards a leprosy-free world - Monitoring and Evaluation Guide [Internet]. Global leprosy strategy 2016-2020. New Delhi: WHO Regional Office for South-East Asia; 2017 p. 102 p. Available from: http://apps.who.int/iris/bitstream/10665/254907/1/9789290225492-eng.pdf
Type
1.
Rada EM, Duthie MS, Bellorín D, Morales S, Crespo L. Clinical Presentation and Serum Antibody Reactivity of Leprosy Patients Attending a Dermatology Clinic in Caracas, Venezuela. Leprosy review [Internet]. 2017;88(1):131-4. Available from: https://leprosyreview.org/article/88/1/13-1141
Type
1.
Pinho RDB. [Control of leprosy in basic health care in Brazil: Analysis of structure factors and work process] [Internet]. [São Luis]: Universidade Federal do Maranhão; 2017. Available from: https://tedebc.ufma.br/jspui/handle/tede/1237
Pagination
- Previous page
- Page 236
- Next page